ACE and diabetes mellitus: In the present registry, no difference in the rate of target BP achievement was found in the gender and BMI subgroups; however, patients with newly diagnosed hypertension, those aged 50–69 years, and those without diabetes were more likely to reach the target value if treated with AZL-M rather than an ACE-inhibitor.